Is there efficacy beyond cytotoxic chemotherapy for pancreatic cancer?

Aparna Kalyan; Al B. Benson

doi:10.1200/JOP.2016.015883

Is there efficacy beyond cytotoxic chemotherapy for pancreatic cancer?

Aparna Kalyan^*, Al B. Benson

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	806-807
Number of pages	2
Journal	Journal of oncology practice
Volume	12
Issue number	9
DOIs	https://doi.org/10.1200/JOP.2016.015883
State	Published - Sep 2016

ASJC Scopus subject areas

Oncology
Oncology(nursing)
Health Policy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JOP.2016.015883

Cite this

@article{561be143a7124aeda9fb8d23cdcac02c,

title = "Is there efficacy beyond cytotoxic chemotherapy for pancreatic cancer?",

author = "Aparna Kalyan and Benson, {Al B.}",

note = "Funding Information: Bristol-Myers Squibb (Inst) Genentech (I), Gilead Sciences, Amgen, Astellas Pharma, Advanced Accelerator Applications, Bayer, Onyx Pharmaceuticals, Novartis, Alchemia, AVEO, Infinity Pharmaceuticals, Merck Serono (Inst), EMD Serono (Inst)",

year = "2016",

month = sep,

doi = "10.1200/JOP.2016.015883",

language = "English (US)",

volume = "12",

pages = "806--807",

journal = "Journal of Oncology Practice",

issn = "1554-7477",